This is the authors' abstract. We don't add key points for this paper.
In efforts to synthesize a clear understanding of SARS-CoV-2 protective immunity, antibody analysis has been paralleled by T cell studies across asymptomatic, mild and severe COVID-19. Defining CD4 and CD8 effector functions in protection is important considering that antibody responses appear short-lived and T cell memory is potentially more durable. To fully understand population level immunity, screening for both antibody and T cell immunity using standardized testing methods would be beneficial.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Altmann et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: